Highlights

May. 19 Boston Scientific Corporation Announces Positive Results from Pivotal Fracture Ide Trial of Seismiq 4Ce Coronary Intravascular Lithotripsy Catheter CI
May. 18 Sector Update: Healthcare Stocks Advance Late Afternoon MT
May. 18 Boston Scientific Makes Third Attempt at TAVR Market, Needham Says MT
May. 18 Boston Scientific Sets $2 Billion Accelerated Stock Buyback DJ
May. 18 Boston Scientific Enters $2 Billion Accelerated Share Repurchase Agreement With JPMorgan MT
May. 18 Boston Scientific invests $1.5 billion in MiRus with option to buy heart-valve business RE
May. 18 Boston Scientific enters into $2 billion accelerated share repurchase agreement RE
May. 18 Boston Scientific Buys 34% Stake in MiRus for $1.5 Billion DJ
May. 18 Boston Scientific Invests $1.5 Billion in MiRus MT
May. 18 Boston Scientific announces strategic investment in MiRus RE
May. 08 Fda Expands Recall of Boston Scientific Cardiac Resynchronization Therapy Devices Following Software Update Advisory CI
May. 08 FDA Issues Most Serious Recall for Certain Pacemaker Devices by Boston Scientific CI
May. 08 FDA Issues Recall for Multiple Boston Scientific Pacemakers Over Software Advisory Expansion CI
May. 07 US FDA issues recall of Boston Scientific heart devices RE
May. 01 Tranche Update on Boston Scientific Corporation's Equity Buyback Plan announced on December 14, 2020. CI
Apr. 29 HEALTH ROUNDS-Procedure using Boston Scientific device tops medication for heart rhythm problem RE
Apr. 26 Boston Scientific Corporation Provides Data At Heart Rhythm 2026 Highlight Key Boston Scientific Therapies CI
Apr. 22 Boston Scientific Corporation Provides Earnings Guidance for the Second Quarter and Full Year 2026 CI
Apr. 22 Boston Scientific Tops First-Quarter Results, Cuts Full-Year Outlook MT
Apr. 22 Boston Scientific cuts annual forecast, shares rise on reset RE
Apr. 22 Boston Scientific Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Apr. 22 Boston Scientific cuts 2026 profit forecast, trims revenue growth view RE
Apr. 22 Boston Scientific Q1 Adjusted Earnings, Net Sales Increase; 2026 Guidance Lowered MT
Apr. 22 Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adjusted EPS View DJ
Apr. 22 (BSX) Boston Scientific Expects 2026 Adjusted EPS Range $3.34 to $3.41, vs. FactSet Est of $3.45 MT
No results for this search